CHAMPAIGN, Ill., July 28, 2020 (GLOBE NEWSWIRE) — (Nasdaq: BUSE)Message from our President & CEOSecond Quarter Financial ResultsThe net income for First […]
The randomized, double-blind GEM-3 trial will compare repeat dosing of either B-VEC or placebo in approximately 30 dystrophic epidermolysis bullosa […]